Axiom Investors’s Immunomedics Inc IMMU Stock Holding History

Axiom Investors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,060	Closed	-$1.96M	–	141
2020 Q3	$1.96M	Sell	23,060 -108,260	-82%	-$5.47M	0.03%	93
2020 Q2	$4.65M	Buy	+131,320	New	+$3.84M	0.09%	77
2018 Q4	–	Sell	-82,480	Closed	-$1.72M	–	152
2018 Q3	$1.72M	Sell	82,480 -51,370	-38%	-$1.22M	0.05%	122
2018 Q2	$3.17M	Buy	133,850 +14,405	+12%	+$290K	0.1%	107
2018 Q1	$1.75M	Sell	119,445 -11,680	-9%	-$191K	0.04%	128
2017 Q4	$2.12M	Sell	131,125 -69,462	-35%	-$820K	0.05%	118
2017 Q3	$2.8M	Buy	200,587 +3,714	+2%	+$37K	0.06%	109
2017 Q2	$1.74M	Buy	196,873 +44,153	+29%	+$310K	0.04%	124
2017 Q1	$988K	Buy	+152,720	New	+$774K	0.03%	143

Axiom Investors's IMMU Position: Q4 2020 in Review

Axiom Investors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 23,060 shares — an estimated $1.96M sold.

Axiom Investors first reported a position in IMMU in Q1 2017 and held it in 9 quarters. The position peaked at $4.65M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Axiom Investors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Axiom Investors sold 23,060 Immunomedics Inc shares in Q4 2020, an estimated $1.96M.
Axiom Investors first reported a position in Immunomedics Inc in Q1 2017 and held it in 9 quarters.
Axiom Investors's Immunomedics Inc position peaked at $4.65M in Q2 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Axiom Investors's 13F filing for Q4 2020, filed 12 Feb 2021.